Undisclosed Biotechnology Companies

Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Genomtec is a biotechnology company that develops mobile technology designed for molecular diagnostics.

CapeHaven is a biotech venture builder that focuses on developing therapeutics into financeable businesses.

4D Path uses H&E biopsy images to unveil hidden data instantly providing biomarker profiling and stratification.

Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.

ReAlta is a clinical-stage biotech company that develops a new class of drugs to address life-threatening diseases.

ImmunoScape offers a tech platform that allows profiling and characterization of the human immune response.

GenoPalate analyzes genetic data, demographics, and lifestyle information to deliver personalized insights for optimal healthy eating.

Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.

MeOmics Technology is a biotech firm specializing in mental health diagnosis and treatment improvement.

Elysium Therapeutics is a health care company that focuses on biotechnology, fitness, medical, and robotics.

Sarmal is a genomics company innovating affordable sequencing and rapid nucleic acid diagnostics.

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

Recludix pharma is a developing platform to treat cancer patients.

The Colossal Foundation providing the cutting-edge science and technology to new generation of conservation leaders.

Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.

Edison Scientific accelerates scientific discovery using an AI research platform for autonomous R&D.

One-carbon Therapeutics offers scientific solutions for treatment against MTHFD1/2 cancer proteins and related targets.

Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.

Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.

Moat Biotechnology is a biopharmaceutical company in the clinical development stage.

Gnosko provides the only real-time inventory automation solution in the Life Sciences Industry.

Prolifagen develops microRNA-based therapies for cardiac regeneration, aiming to prevent heart failure.